Bronchoscopy in healthy volunteers

Journal of Bronchology

Volumn 5, Issue 3, 1998, Pages 185-194

  Ghio, Andrew J ^a,c   Bassett, Maryann ^a   Chall, Alexandria N ^a   Levin, Debra G ^a   Bromberg, Philip A ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Bronchoscopy; Case control studies; Reference values

Indexed keywords

EID: 0000765838     PISSN: 10708030     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128594-199807000-00003     Document Type: Article

References (66)

1. Prakash UBS, Offord KP, Stubbs SE. Bronchoscopy in North America: the ACCP survey. Chest 1991;100:1668-75.
2. Pue CA, Pacht ER. Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995;107:430-2.
3. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140: 1745-53.
4. Jarjour NN, Calhoun WJ, Schwartz LB, Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 1991;144:83-7.
5. Chetta A, Foresi A, Bertorelli G, Pesci A, Olivieri D. Lung function and bronchial responsiveness after bronchoalveolar lavage and bronchial biopsy performed without premedication in stable asthmatic subjects. Chest 1992;101:1563-8.
6. Gratziou C, Carroll M, Walls A, Howarth PH, Holgate ST. Early changes in T lymphocytes recovered by bronchoalveolar lavage after local allergen challenge of asthmatic airways. Am Rev Respir Dis 1992;145:1259-64.
7. Van Vyve T, Chanez P, Bousquet J, Lacoste JY, Michel FB, Godard P. Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity. Am Rev Respir Dis 1992;146:116-21.
8. Vittori E, Marini M, Fasoli A, De Franchis R, Mattoli S. Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis 1992; 146:1320-5.
9. Van Vyve T, Chanez P, Lacoste JY, Bousquet J, Michel FB, Godard P. Assessment of airway inflammation in asthmatic patients by visual endoscopic scoring systems. Eur Respir J 1993;6: 1116-21.
10. Kraft M, Beam WR, Wenzel SE, Zamora MR, O'Brien RF, Martin RJ. Blood and bronchoalveolar lavage endothelin-1 levels in nocturnal asthma. Am J Respir Crit Care Med 1994;149:946-52.
11. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am Rev Respir Dis 1989;140:1527-37.
12. Thompson AB, Huerta G, Robbins RA, et al. The bronchitis index: a semiquantitative visual scale for the assessment of airways inflammation. Chest 1993;103:1482-8.
13. Weinberger SE, Kelman JA, Elson NA, et al. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978;89:459-66.
14. Low RB, Giancola MS, King TE Jr, Chapitis J, Vacek P, Davis GS. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992;146:701-6.
15. Midulla F, Villani A, Merolla R, Bjermer L, Sandstrom T, Ronchetti R. Bronchoalveolar lavage studies in children without parenchymal lung disease: cellular constituents and protein levels. Pediatr Pulmonol 1995;20:112-8.
16. Halperin SA, Suratt PM, Gwaltney JM Jr, Groschel DH, Hendley JO, Eggleston PA. Bacterial cultures of the lower respiratory tract in normal volunteers with and without experimental rhinovirus infection using a plugged double catheter system. Am Rev Respir Dis 1982;125:678-80.
17. Halperin SA, Eggleston PA, Hendley JO, Suratt PM, Groschel DH, Gwaltney JM Jr. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis 1983;128: 806-10.
18. Halperin SA, Eggleston PA, Beasley P, et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985;132:976-80.
19. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:2200-8.
20. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879-86.
21. Ohar JA, Jackson F, Dettenmeier PA, Bedrossian CW, Tricomi SM, Evans RG. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis. Chest 1992;102:999-1004.
22. 3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986;60:1321-6.
23. Koren HS, Devlin RB, Graham DE, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407-15.
24. Devlin RB, McDonnell WF, Mann R, et al. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 1991;4:72-81.
25. Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993; 148:1363-72.
26. Aris R, Christian D, Tager I, Ngo L, Finkbeiner WE, Balmes JR. Effects of nitric acid gas alone or in combination with ozone on healthy volunteers. Am Rev Respir Dis 1993;148:965-73.
27. Hazbun ME, Hamilton R, Holian A, Eschenbacher WL. Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568-72.
28. Devlin RB, McKinnon KP, Noah T, Becker S, Koren HS. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am J Physiol 1994;266:L612-9.
29. Nadziejko C, Finkelstein I, Balmes JR. Contribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation. Am J Respir Crit Care Med 1995;152:1592-8.
30. Weinmann GG, Liu MC, Proud D, Weidenbach-Gerbase M, Hubbard W, Frank R. Ozone exposure in humans: inflammatory, small and peripheral airway responses. Am J Respir Crit Care Med 1995; 152:1175-82.
31. Coffey MJ, Wheeler CS, Gross KB, Eschenbacher WL, Sporn PH, Peters-Golden M. Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology 1996;114: 187-97.
32. Devlin RB, McDonnell WF, Becker S, et al. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol Appl Pharmacol 1996;138:176-85.
33. Frampton MW, Finkelstein JN, Roberts NJ Jr, Smeglin AM, Morrow PE, Utell MJ. Effects of nitrogen dioxide exposure on bronchoalveolar lavage proteins in humans. Am J Respir Cell Mol Biol 1989;1:499-505.
34. Frampton MW, Smeglin AM, Roberts NJ Jr, Finkelstein JN, Morrow PE, Utell MJ. Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro. Environ Res 1989;48:179-92.
35. Sandstrom T, Andersson MC, Kolmodin-Hedman B, Stjernberg N, Angstrom T. Bronchoalveolar mastocytosis and lymphocytosis after nitrogen dioxide exposure in man: a time-kinetic study. Eur Respir J 1990;3:138-43.
36. Rubinstein I, Reiss TF, Bigby BG, Stites DP, Boushey HA Jr. Effects of 0.60 ppm nitrogen dioxide on circulating and bronchoalveolar lavage lymphocyte phenotypes in healthy subjects. Environ Res 1991;55:18-30.
37. Sandstrom T, Stjernberg N, Eklund A, et al. Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: a dose-response study. Eur Respir J 1991;4:332-9.
38. Sandstrom T, Helleday R, Bjermer L, Stjernberg N. Effects of repeated exposure to 4 ppm nitrogen dioxide on bronchoalveolar lymphocyte subsets and macrophages in healthy men. Eur Respir J 1992;5:1092-6.
39. Sandstrom T, Ledin MC, Thomasson L, Helleday R, Stjernberg N. Reductions in lymphocyte subpopulations after repeated exposure to 1.5 ppm nitrogen dioxide. Br J Ind Med 1992;49:850-4.
40. Helleday R, Huberman D, Blomberg A, Stjernberg N, Sandstrom T. Nitrogen dioxide exposure impairs the frequency of the mucociliary activity in healthy subjects. Eur Respir J 1995;8:1664-8.
41. Kelly FJ, Blomberg A, Frew A, Holgate ST, Sandstrom T. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Am J Respir Crit Care Med 1996;154:1700-5.
42. Sandstrom T, Stjernberg N, Andersson MC, et al. Cell response in bronchoalveolar lavage fluid after exposure to sulfur dioxide: a time-response study. Am Rev Respir Dis 1989;140:1828-31.
43. Frampton MW, Voter KZ, Morrow PE, et al. Sulfuric acid aerosol exposure in humans assessed by bronchoalveolar lavage. Am Rev Respir Dis 1992;146:626-32.
44. Frampton MW, Morrow PE, Cox C, et al. Sulfuric acid aerosol followed by ozone exposure in healthy and asthmatic subjects. Environ Res 1995;69:1-14.
45. Salvi SS, Blomberg A, Rudell B, et al. Acute inflammatory changes in the airways of healthy human subjects following short term exposure to diesel exhaust [abstract]. Am J Respir Crit Care Med 1997;155:A425.
46. Abboud RT, Fera T, Richter A, Tabona MZ, Johal S. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid. Am Rev Respir Dis 1985;131:79-85.
47. Rosenthal E. New York seeks to tighten rules on medical research. New York Times, Sept 27, 1996.
48. Morris AH, Kanner RE, Crapo RO, Gardner RM. Clinical pulmonary function testing. Salt Lake City: Intermountain Thoracic Society, 1984.
49. Karetzky MS, Garvey JW, Brandstetter RD. Effect of fiberoptic bronchoscopy on arterial oxygen tension. N Y State J Med 1974; 74:62-3.
50. Ettensohn DB, Jankowski MJ, Redondo AA, Duncan PG. Bronchoalveolar lavage in the normal volunteer subject. 2. Safety and results of repeated BAL, and use in the assessment of intrasubject variability. Chest 1988;94:281-5.
51. Pearce SJ. Fibreoptic bronchoscopy: is sedation necessary? BMJ 1980;281:779-80.
52. Simpson FG, Arnold AG, Purvis A, Belfield PW, Muers MF, Cooke NJ. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax 1986;41:311-7.
53. Colt HG, Morris JF. Fiberoptic bronchoscopy without premedication: a retrospective study. Chest 1990;98:1327-30.
54. Credle WF Jr, Smiddy JF, Elliott RC. Complications of fiberoptic bronchoscopy. Am Rev Respir Dis 1974;109:67-72.
55. Suratt PM, Smiddy JF, Gruber B. Deaths and complications associated with fiberoptic bronchoscopy. Chest 1976;69:747-51.
56. Pereira W Jr, Kovnat DM, Snider GL. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 1978;73:813-6.
57. Dreisin RB, Albert RK, Talley PA, Kryger MH, Scoggin CH, Zwillich CW. Flexible fiberoptic bronchoscopy in the teaching hospital: yield and complications. Chest 1978;74:144-9.
58. Lukomsky GI, Ovchinnikov AA, Bilal A. Complications of bronchoscopy: comparison of rigid bronchoscopy under general anesthesia and flexible fiberoptic bronchoscopy under topical anesthesia. Chest 1981;79:316-21.
59. Labedzki L, Ochs HR, Abemethy DR, Greenblatt DJ. Potentially toxic serum lidocaine concentrations following spray anesthesia for bronchoscopy. Klin Wochenschr 1983;61:379-80.
60. Cacace L. Sinus standstill from lidocaine. JAMA 1973;224:1428.
61. Cheng TO, Wadhwa K. Sinus standstill following intravenous lidocaine administration. JAMA 1973;223:790-2.
62. Olsen ML, McAvoi GK. Methemoglobinemia induced by local anesthetics. Am J Hosp Pharm 1981;38:89-93.
63. Kotler RL, Hansen-Flaschen J, Casey MP. Severe methaemoglobinaemia after flexible fibreoptic bronchoscopy. Thorax 1989;44: 234-5.
64. Hansen-Flaschen J. Methemoglobinemia after lidocaine administration [letter]. Chest 1990;98:519-20.
65. Ameer B, Burlingame MB, Harman EM. Systemic absorption of topical lidocaine in elderly and young adults undergoing bronchoscopy. Pharmacotherapy 1989;9:74-81.
66. National Institutes of Health Workshop Summary. Summary and recommendations of a workshop on the investigative use of fiber-optic bronchoscopy and bronchoalveolar lavage in individuals with asthma. J Allergy Clin Immunol 1985;76:145-7.